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Abstract 
Background 
Previous studies indicate that South Asians (SA) may have a reduced risk of developing atrial 
fibrillation (AF) despite having a higher prevalence of traditional cardiovascular risk factors. This 
observational study was designed to explore the relative differences between SAs and Whites in a 
well-defined, multi-ethnic population with careful consideration of traditional cardiovascular risk 
factors that are thought to contribute to the development of AF. 
Methods and Results 
Anonymised data from 417,575 adults was sourced from primary care records within Bradford 
Metropolitan District, UK. AF diagnosis was indicated by presence on the AF QOF register. Self-
reported ethnicity was mapped to census ethnic codes. 
The age-standardised prevalence rates of AF were calculated for comparison between the White 
and SA populations; our study sample presented relative proportions of 2.39% and 0.4%. 
Multivariable logistic regression analysis was performed to estimate the odds of developing AF given 
SA ethnicity. Adjustment for age, sex and established risk factors  found a 71% reduction in odds of 
AF in SAs when compared to Whites (OR: 0·29, 95% CI: 0·26 –0·32). When stratified by ethnicity, 
analyses revealed significantly different odds of AF for patients with diabetes; diabetes was not 
associated with development of AF in the SA population (0.81; 95% CI: 0.63-1.05).  
Conclusions 
This study, in a multi-ethnic population, presents ethnicity as a predictor of AF where prevalence is 
significantly lower in SAs compared to Whites. This is despite SAs having a higher frequency of 
established risk factors for the development of AF, such as IHD, heart failure, hypertension and type 
2 diabetes. These findings are consistent with previous literature and add weight to the need for 
further investigation, though this is the first study to investigate the differential associations of 
individual risk factors with development of AF. 
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Introduction 
Atrial fibrillation (AF) affects 1-2% of the general population, and its prevalence is expected to double 
over the next 50 years (1). It is associated with a 4-5 times increase in stroke risk (2) and a 1·5-1·9 
fold increased risk in mortality (3). Patients with AF also have reduced cardiac output which leads to 
heart failure; this results in an increased frequency of hospital admissions (1) and reduced quality of 
life. 
The established major risk factors for developing AF are high blood pressure, coronary heart 
disease, heart failure, diabetes and age (1). Currently there are no effective strategies to prevent 
development and the mainstay of management is treatment of the condition once it manifests. The 
management of AF can be challenging (1). 
Previous research finds a lower prevalence of AF in the South Asian (SA) population compared to 
White Europeans despite a higher prevalence of established risk factors such as diabetes and 
coronary artery disease (4) (5) (6) (7). Population characteristics are not well defined with regards 
to hypertension where some studies report that SAs have a higher prevalence and others report 
lower, although age is often overlooked (8) (9). Ethnicity in such research is not often well defined 
and samples may not be representative according to census data. If SAs have a lower prevalence 
of AF despite having higher traditional cardiovascular risk factors, understanding the reasons may 
have implications for primary preventative strategies. 
Bradford metropolitan district (BMD) has an SA population of 26.83% (10) and the largest proportion 
of people of Pakistani ethnic origin (20·3%) (10). The predominant SA population of Bradford 
comprises individuals who immigrated to the UK from Mirpur district (Pakistan) in the 1950-1960s 
and their progeny (11). This unique setting allows a novel comparison of SAs (with common 
genealogy) and Whites, whilst minimising potential bias from confounding environmental factors. 
This observational study was therefore designed to explore the association between SA ethnicity 
and development of AF in a well-defined multi-ethnic population with consideration of traditional 
cardiovascular risk factors.  
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Methods 
Anonymised records of all adults (aged 18+) registered with a GP in BMD as of 01/07/2013 were 
sourced from the General Practice (GP) database, SystmOne, of all adult patients (aged 18+) 
registered as of 01/07/2013 with a GP in BMD. The district has an adult population of 385,873 and 
data from all 82 GPs in BMD was obtained. 
The data export was undertaken by the West and South Yorkshire and Bassetlaw Commissioning 
Support Unit. The dataset contained demographic variables including age, sex and self-reported 
ethnicity, along with prescribed cardiovascular medication and whether the patient had been 
included on any of the following Quality Outcomes Framework (QOF) registries: AF, diabetes, heart 
failure, hypertension, peripheral arterial disease, ischemic heart disease or stroke. 
Data preparation 
Data were stored in a relational SQL database and scripts were written to ‘clean’ the dataset in 
preparation for analysis, generating the necessary derived variables. 
Ethnicity values within the GP dataset were Read Coded. These codes provide a ‘thesaurus of 
clinical terms’ and are used to document patient findings and procedures in information technology 
systems throughout primary care in the UK. Values were mapped to the 18 national Ethnic Category 
codes, as used in the 2001 and 2011 census’ (using previous studies as guidance), and are the 
accepted standard in the NHS Data Model and Dictionary for England Version 3. For the purposes 
of these analyses, we used the six higher-level categories: White, Mixed, Asian or Asian British, 
Black or Black British, Other Ethnic Group and Not stated. As the national codes do not differentiate 
between the Asian sub-regions we used the definition rendered by the United Nations (12) to 
determine those countries that are considered to be SA (see Supplementary file 1). Only those 
patients that were mapped to White or SA categories were used in the analysis. 
The QOF registry data was cleaned to provide a binary data format; those records that were neither 
marked positively nor negatively were re-coded as negative. AF diagnosis was indicated by a patient 
being placed on the AF QOF register by their GP; these patients were assigned diagnostic Read 
Codes (v3) G5730% or G573.% in their electronic medical record. Atrial fibrillation resolved, coded 
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as Read Code v3 XaLFz, is excluded from the QOF dataset. Analysis was not possible in 6714 
patients because of missing data in key QOF and/or medical history fields. 
The study population was compared for proportional equivalence with the latest available census 
data (27/03/2011) for the BMD with regards to ethnicity and sex for each age category. We also 
explored the proportional change in ethnic representation between 2001 and 2011 based on the 
Census data for both Bradford and England and Wales. 
Data for each of the risk factors (aged 65-74, aged ≥75, diabetes, heart failure, ischaemic heart 
disease, peripheral arterial disease and hypertension) were also derived from the dataset. 
Statistical methods 
All analyses were conducted using the statistical package R (The R Project for Statistical Computing) 
(13). 
Crude prevalence of AF in the study population was calculated using the complete adult (18+) 
general practice population. Direct standardization for age was conducted by matching to the 2011 
Bradford Census (14). 
The prevalence of AF and established risk factors were compared between the two ethnic subgroups 
using the two-proportion z-test. False discovery rate (FDR) correction for multiple testing was used. 
In order to acknowledge the variation in age distribution between these populations, data were also 
examined in three age groups. 
In the first instance, multivariable logistic regression analysis was performed to estimate the odds of 
developing AF when South Asian compared with White.  The complete regression model adjusted 
for age, sex, hypertension, heart failure, diabetes and ischemic heart disease. The minimum 
sufficient set of confounders was identified using a Directed Acyclic Graph (DAG) tool (15) with 
guidance from a priori clinical knowledge. The continuous variable age was discretised to reflect 
those categories considered to be of clinical relevance (<65, 65-74, ≥75); the remaining covariates 
were included dichotomously, denoting whether or not the diagnosis was present. 
Data were then stratified by ethnicity and subgroup analyses were performed to investigate the 
differential odds of AF given each of the potential risk factors; separate multivariable logistic 
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regression models were fit to characterise the exposure-outcome relationships for each risk factor 
as directed by individual DAGs. A total of 14 models were run (Supplementary file 2); model fit was 
assessed by generation of ROC (Receiver Operating Characteristic) curves, with consideration of 
the area under the curve (AUC) values obtained. Odds ratios were estimated for the covariates 
previously mentioned and presented graphically as a forest plot to allow visual comparison 
between ethnicities. 
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Results 
The dataset comprised a total of 417,575 individuals registered at BMD practices; this figure is 8% 
greater than the 2011 census population (385,873) (14) and 21.2% higher than the 2001 census 
(344,600) (16). A total of 6714 subjects were not considered for analysis due to incomplete data 
(Figure 1). The remaining GP records were classified into 177 distinct ethnicity Read Codes. 
Approximately 6.9% (28,715) of our population could not be resolved to an ethnic category; Read 
Codes present in the GP record were equivalent to ‘not otherwise specified’ or ‘not stated’. Complete 
case analysis was conducted upon 277,218 cases, where only White (204,193) and South Asian 
(73,025) data were retained (Figure 1).  
As the Census dataset does not strictly classify SA as a sub-set, distribution of the total Asian 
population from the 2011 Bradford Census was compared to these data in terms of ethnic category, 
sex and age. By proportion, our datasets were not significantly different for any sex/age/ethnicity 
combination; this validates our representation of the Bradford population. 
The SA sample has a mean age approximately 10 years lower than that of the White population 
(White: 48·85 (SD:18·93), SA: 39·39 (SD:15·58)) (Figure 2). The age distribution in SAs is skewed 
(where the population is younger), compared with Whites. 
For the entire population, we detected a 1·91% crude prevalence of AF (5304 cases). The total age 
adjusted prevalence was 2·39% and 0.4% for Whites and SAs respectively (Table 2). As the 
population distribution SAs and Whites is very different (Figure 2), we grouped individuals into three 
different age brackets; 50-65 (Table 1b), 65-79 (Table 1c) and 80+ (Table 1d). The prevalence of AF 
was lower in SAs compared to Whites despite the significantly higher prevalence of “traditional” risk 
factors for AF (i.e. hypertension, diabetes, coronary disease and heart failure) (Table 1b-d, Figure 
3). Furthermore, when adjusted for age, sex, heart failure, hypertension, diabetes and ischemic heart 
disease, multivariable logistic regression analyses demonstrated a 71% reduction in odds of AF in 
SAs when compared to Whites (OR: 0·29, 95% CI: 0·26 –0·32). An AUC value of 0.91 was obtained 
for this model. 
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Further regression analyses determined the role of individual cardiovascular risk factors of AF within 
each ethnic group. In both cohorts, hypertension, heart failure, IHD and aging significantly increased 
the likelihood of developing AF.  However, diabetes did not increase the odds of AF in the SA sample 
(0.81; 95% CI: 0.63-1.05), but did so in Whites (1.28; 95% CI: 1.19-1.38). Additionally, White females 
were less likely to have AF compared to SA females (Figure 4). The association between AF and 
co-morbid diabetes and hypertension was also explored to find that within the SA sample (n=121), 
the odds ratio for AF with diabetes and hypertension as a combined risk factor is 0.76 (CI: 0.57-
1.01). In whites (n=944), the odds ratio was 1·45 (1·33-1·57). All models demonstrate good fit with 
a range of AUC values between 0.87 and 0.9. 
 
Discussion 
Bradford is the 4th largest metropolitan district in England and has a SA population of 26%. The 
majority of the SA population are of Pakistani ancestry (77%), with a large proportion originating from 
the small Mirpur District of South Azad Kashmir, Pakistan (11). This is the first study to investigate 
the prevalence of AF within distinct ethnic groups residing in a shared environment, where the 
majority of the SAs share similar genealogy. Comparisons are made between White and SA cohorts 
from a stable resident population with low mobility – the influence of environmental factors is 
therefore similar for both groups. Stratified regression modelling was used to explore the differential 
effects of ethnicity and define the association of cardiovascular risk factors with AF prevalence. 
Confidence intervals produced for all models using SA data are notably wider than those for White 
data and this is likely attributable to the difference in sample size; however this did not significantly 
detract from model fit. 
 
The predominantly homogenous nature of the sample is advantageous where inclusion of any other 
SA population, such as those from the Indian subcontinent for example, brings complications due to 
the differential incidence of rheumatic mitral valve disease (17). Ethnicity data from this study is self-
reported, which has been shown to be more accurate than when coding is completed by an 
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independent observer (18). These data are consistent with census population counts and 
importantly, the overall prevalence of AF in our cohort is in line with previous published data. 
This dataset comprised 145 SA AF patients >75 years old and although this number is slightly 
smaller than analysed in previous literature (5), the difference is minimal. The ethnic origin of patients 
within this group was strictly defined prior to analysis and this, together with the homogeneity of the 
sample population, gives strength to the publication that other publications do not share.  
  
A further strength is the use of QOF coded data for indication of the presence of AF and relevant 
comorbidities. As all GPs in Bradford use SystmOne, and data collection is incentivised under the 
QOF scheme, maximal data completion is encouraged. QOF data is considered to be one of the 
most reliable datasets immediately available as it is required to calculate payments as part of the 
GP contracts, hence there is financial incentive to ensure that data are collected and recorded 
accurately.  
 
Using these data, obtained as part of routine healthcare, we add support to previous literature with 
demonstration of a significantly lower age-standardised prevalence of AF within the SA population 
when compared to Whites, despite having a higher proportion of cardiovascular disease, heart 
failure, diabetes and hypertension. This is the first study to examine the ethnic differences in 
aetiology rather than the resulting disease, and multivariable analyses translated this to a 71% 
reduction in odds of developing AF for SA patients. Ethnicity alone was identified to have a strong 
association with development of AF in adjusted analyses which demonstrated excellent predictive 
ability by AUC.  In both groups, hypertension was found to have a strong association with AF. 
However, while White patients with diabetes have increased odds of AF, no association was found 
for SAs. It appears that the effect of hypertension is therefore somehow blunted in SAs, and this may 
be in association with diabetes. Explorative analyses found a paradoxical relationship between the 
combination of hypertension and diabetes in SA compared to Whites, in that while statistically non-
significant, the odds for AF reduce for patients with both risk factors in SAs but not in Whites.  Could 
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this be because in SAs, diabetes as a precursor for hypertension has a different pathophysiological 
mechanism to hypertension on its own?  
 
We cannot conclude that diabetes and comorbid diabetes and hypertension have a differential 
mechanism in the development of AF without further evidence to validate this finding. No data are 
currently available to determine why, where established risk factors are more prevalent in SAs, the 
prevalence of AF is lower. There are a number of potential underlying mechanisms that may explain 
this, however.  For example, there may be morphological differences between the White and SA 
heart. 
There is evidence to suggest that the SA left atrium is smaller than the White atrium and this appears 
to be associated with a smaller body surface (19). A smaller LA may explain this discrepancy where 
early evidence from animal experiments showed that smaller mammals do not sustain AF because 
their atria do not have critical mass to allow the arrhythmia to perpetuate (20). This has also been 
demonstrated more recently by Allessie et al (21). Whilst this theory is interesting, conditions such 
as heart failure and hypertension would increase left ventricular end diastolic pressure and raise left 
atrial pressure causing atrial stretching and expansion. The SA atrium may be more resistant to this 
effect, or the process may take longer in SAs as the atrium is smaller.  More recent data from animal 
studies negates the size hypothesis as the administration of sympathetic agents appears to nullify 
this effect (22). Therefore mechanisms beyond size could be responsible. The allometric scaling 
model may help to explain how size could affect function. Studies on the hearts of a number of 
mammals have suggested that the PR interval is directionally proportional to body mass (23). 
Moreover, data from studies on ventricular fibrillation models appear to support the notion that 
fibrillation cycle length is directly proportional to body mass to the power of ¼ (20). Theoretically, this 
non-linear relationship could translate to different AF cycle lengths in Whites versus SA and lead to 
differing susceptibilities. Part of the difference could be secondary to events at the ion channel level. 
There are reports of sodium channel variants in different ethnic groups which could either be 
protective or make patients more vulnerable to heart rhythm disorders (24). This mechanism is 
intriguing, but requires further work (20). Finally, the extracellular matrix composition may also be 
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different, or the response to fibrosis may be reduced in SAs. Work from our group has demonstrated 
a difference in matrix metalloproteinases in different ethnic groups (25). In addition, variants of the 
angiotensin II type 1 receptor in SAs appear to protect from non-alcoholic fatty liver disease in SA 
(26).  It is possible therefore, that the difference in AF susceptibility is attributable to a different 
genetic makeup. Recently a number of genes have been identified and ethnic associations made 
(27) (28) (29). However, there is little information regarding the genetic profiles of SAs (30). An 
inherited protective effect may explain this difference, which could render the SA atria 
morphologically and physiologically different to that of the White population and potentially explain 
why this effect is evident in many reports (29). 
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Limitations 
Although we feel that the sample is representative, there are a number of limitations. The prevalence 
of AF was derived from the QOF records provided by GP surgeries alone; we have not validated 
these diagnoses by scrutiny of ECGs and this may be a source of error. Further, if a QOF code for 
clinical diagnosis was not present in the record, we have assumed that the patient is free from 
disease. This approach neglects to consider those patients that have AF though have not had 
cardiac rhythm assessment to confirm diagnosis, and also basic errors during data entry – these 
points are true for both subgroups however, and are unlikely to introduce substantial bias. 
 
Continuous variables such as blood pressure and BMI were collected in the original dataset, however 
as large amounts of data were poorly recorded or missing, these were unsuitable for inclusion in 
analyses; residual confounding may therefore remain and is a limitation of this work.  
 
Additionally, we were unable to include unregistered individuals in analyses as data were unavailable 
and although we would expect this to be a small minority of the population, it should be considered 
a potential source of bias. Similarly, although the age, sex and ethnicity breakdown was comparable 
to census data overall, a group of individuals were excluded as their ethnicity was not coded; these 
patients may collectively represent a unique subset. However, despite these flaws, it is unlikely 
that a significant number of individuals have been omitted.  
These analyses do not account for the potential difference in GP attendance rate by population 
subgroup and this may represent failure to address bias, though as all patients reside in the same 
area and therefore have the same access to healthcare, it is likely that all patients would present if 
symptomatic. It is acknowledged that many cases of AF are undiagnosed, though this is not expected 
to vary by ethnicity in this sample.  
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Further work 
Further studies with larger sample sizes in subsets such as that of AF patients with comorbid 
hypertension and diabetes are required to validate the paradoxical reduction in odds for SAs.  
Genetic studies for identification of potential genes that may protect from AF will be important to 
allow the difference in prevalence to be explained. Work also needs to be directed to address the 
concept of anatomical differences between the ethnic groups with imaging. Electrophysiological 
studies should be directed towards assessment of atrial conduction, refractoriness, atrial size and 
vulnerability to scarring. 
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Conclusion 
This multi-ethnic, population-based study shows that the prevalence of AF is significantly lower in 
SAs compared to Whites. This is despite a higher frequency of IHD, type 2 diabetes, heart failure 
and hypertension in the SA population. The total AF prevalence in our cohort is similar to 
population estimates and findings from previous studies; this is important as it validates data 
sampling, and has not been properly accounted for in previous reports. These findings are 
consistent with previous papers and add weight to the need for further investigation with 
demonstration of differential odds of individual risk factors between ethnic subgroups.  
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Figure 1: Flow chart summarising study population & ethnic mapping from the total adult population 
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Figure 2: Population pyramid depicting the age distribution of the study population in ethnic sub-
groups. 
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Figure 3: Age adjusted prevalence of AF in SAs and Whites 
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Figure 4: Adjusted odds ratios and 95% confidence intervals for each traditional risk factor following 
stratification by ethnicity for direct comparison. Estimates are adjusted for the minimum sufficient set 
of confounders deemed appropriate to estimate the direct effect within each exposure-outcome 
relationship (Appendix 2). W, White; SA, South Asian; PAD, peripheral arterial disease; IHD, 
ischaemic heart disease; 65-74 and >74 refer to age groups.  
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Table 1a: Whole population unadjusted for age 
 Total population (277218)  
  
White 
(n=204193) 
% 
South Asian 
(n=73025) 
% P-values * 
Male : Female 95483 : 108710 
46·76 : 
53·24  
37594 : 35431 
51·48 : 
48·52 
 
Age (mean, SD) 48·85 (18·93) - 39.39 (15.58) -  
AF 4968 2·43 336 0·46 <0·001 
Heart failure 2658 1·30 551 0·75 <0·001 
Hypertension 41278 20·22 9994 13·69 <0·001 
Diabetes 15827 7·75 10025 13·73 <0·001 
Peripheral arterial 
disease 
3060 1·50 586 0·80 <0·001 
Ischemic heart 
disease 
12275 6·01 3034 4·15 <0·001 
Stroke 6157 3·02 1017 1·39 <0·001 
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Table 1b: Individuals aged 50-64 
 Total population (58617)  
  
White 
(n=47774) 
% 
South Asian 
(n=10843) 
%  
Male : Female 23344 : 24430 48·86 : 51·14 5510 : 5333 
50·82 : 
49·18 
 
AF 639 1·34 70 0·65 
<0·00
1 
Heart failure 331 0·69 135 1·25 
<0·00
1 
Hypertension 12088 25·30 4196 38·70 
<0·00
1 
Diabetes 4771 9·99 4213 38·85 
<0·00
1 
Peripheral arterial 
disease 
609 1·27 225 2·08 
<0·00
1 
Ischemic heart 
disease 
2622 5·49 1175 10·84 
<0·00
1 
Stroke 1097 2·30 352 3·25 
<0·00
1 
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Table 1c: Individuals aged 65-79 
 Total population (38793)  
  
White 
(n=34095) 
% 
South Asian 
(n=4698) 
%  
Male : Female 16223 : 17872 
47·58 : 
52·42 
2115 : 2583 
45·02 : 
54·98 
 
AF 2092 6·14 146 3·11 
<0·00
1 
Heart failure 1023 3·00 233 4·96 
<0·00
1 
Hypertension 16907 49·59 2910 61·94 
<0·00
1 
Diabetes 6321 18·54 2450 52·15 
<0·00
1 
Peripheral arterial 
disease 
1448 4·25 215 4·58 0·338 
Ischemic heart 
disease 
5414 15·88 1175 25·01 
<0·00
1 
Stroke 2583 7·58 392 8·34 0·083 
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Table 1d: Individuals aged 80+ 
 Total population (14914)  
  
White 
(n=13559) 
% 
South Asian 
(n=1355) 
%  
Male : Female 4844 : 8715 
35·73 : 
64·27 
634: 721 
46·79 : 
53·21 
 
AF 2091 15·42 85 6·27 
<0·00
1 
Heart failure 1228 9·06 154 11·37 0·008 
Hypertension 8663 63·89 862 63·62 0·896 
Diabetes 2701 19·92 652 48·12 
<0·00
1 
Peripheral arterial 
disease 
881 6·50 72 5·31 0·118 
Ischemic heart 
disease 
3825 28·21 380 28·04 0·922 
Stroke 2226 16·42 186 13·73 0·129 
 
Statistical significance estimated by two proportion z-test, * p-values adjusted for multiple testing 
using FDR; *** = p < 0·001 
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Table 2: Age adjusted prevalence of AF by ethnicity 
 White South Asian Significance 
 N 
Cases of 
AF  
Age adj. 
prev (%) 
N Cases 
Age adj. 
prev (%) 
 
18-29 39,594 8 0 22,478 7 0·01 0·56 
30-49 69,176 138 0·07 33,653 28 0·04 *** 
50-64 47,775 639 0·34 10,843 70 0·09 *** 
65-79 34,096 2,092 0·96 4,698 146 0·17 *** 
80+ 13,559 2,091 1·02 1,355 85 0·08 *** 
Total 204,200 4,968 2·390 73,027 336 0·4 *** 
Statistical significance estimated by two proportion z-test, *** = p < 0·001 
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